Anecortave desacetate

Anecortave desacetate (AL-4940) is an angiogenesis inhibitor. Anecortave is indicated for the study of exudative (wet) age-related macular degeneration as well as retinal tumors[1][2].

Product Specifications

CAS Number

[10184-70-0]

Product Name Alternative

AL-4940

UNSPSC

12352211

Target

Biochemical Assay Reagents

Type

Reference compound

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/anecortave-desacetate.html

Purity

98.36

Solubility

DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

C[C@]12CCC(C=C1CC[C@@H]3C2=CC[C@]4([C@H]3CC[C@@]4(C(CO)=O)O)C)=O

Molecular Formula

C21H28O4

Molecular Weight

344.44

References & Citations

[1]Kaiser PK, et al. Posterior juxtascleral depot administration of anecortave acetate. Surv Ophthalmol. 2007 Jan;52 Suppl 1:S62-9. |[2]Jockovich ME, et al. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH (BETA) T (AG) mice. Invest Ophthalmol Vis Sci. 2006 Apr;47 (4) :1264-8.